Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from GlaxoSmithKline.

Advances In™: Are You Up-to-Date on Vaccinations? Incorporating Guideline-Based Care to Ensure Shingles Prevention in Your Patients

Release Date: May 10, 2021
Expiration Date: May 10, 2022

Activity Overview

This online educational activity is designed to provide expert interpretation of new data on the prevention of herpes zoster. Nearly a third of the United States’ population will develop shingles over their lifetime, and the risk of shingles increases with age. Emerging data on herpes zoster prevention in special populations, and best practices to implement shingles vaccination in your clinical practice will be presented in a multimedia format with a series of video interviews from an expert thought leader, integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from GlaxoSmithKline.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward all health care providers who are involved with vaccination of patients for shingles.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Recognize the disease burden, cost of care, and long-term sequelae associated with herpes zoster infection
Review the administration characteristics, composition, and features of available shingles vaccines
Evaluate the efficacy data associated with available shingles vaccine
Develop therapeutic plans for administration of shingles vaccines in appropriate patient groups

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible entities.

Faculty

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Adult/Family Nurse Practitioner
Owner – Wright & Associates Family Healthcare
Concord and Amherst, NH

Disclosures: Consultant: GlaxoSmithKline, Merck & Co., Pfizer, Sanofi–Vaccines, OA/Pain; Speakers Bureau: Allergan, Biohaven Pharmaceuticals, Merck & Co., Pfizer, Sanofi–Vaccines.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.